Report reflects cautious investor optimism about global economy
A Japanese health ministry panel on Wednesday recommended approving Pfizer Inc's Covid-19 vaccine for children as young as six months old.
Japan in January expanded use of the vaccine to those as young as five years old. Last month, health authorities started dispensing Pfizer and Moderna Inc booster shots that target the Omicron variant of the virus.
The panel also recommended approval of a version of the Pfizer vaccine that protects against the BA.4 and BA.5 subvariants of Omicron. Moderna said earlier on Wednesday it was seeking Japanese approval of its own subvariant shot.
ALSO READ:
Report reflects cautious investor optimism about global economy
Policy focuses on international trade settlement in rupees
With attitudes towards circularity in fashion changing, a look at the preloved fashion market in the UAE
Meng on Friday identified Huawei's cloud business as a key area of growth
The US is heading down a road it has never travelled before, one fraught with profound consequences for the health of the world’s oldest democracy
New chief will lead the company for six months until September 30
The reduction comes after two consecutive months of increases, bringing relief to residents